MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
An Interview With Ralph Stephan von Bardeleben, MD
Dr. von Bardeleben provides insight into ongoing mitral valve trials and discusses use of mitral devices for tricuspid disease, as well as imaging protocols for transcatheter mitral valve interventions.
Use of the MitraClip Device in Practice
An update on the European registry experience.
By Ralph Stephan von Bardeleben, MD, and Wolfgang Schillinger, MD
NeoChord Nexus TMVR Device Successfully Used in First-In-Human Procedure
October 4, 2021—NeoChord, Inc. announced the successful completion of the first-in-human procedure with the NeoChord Nexus transcatheter mitral chordal repair (TMVR) technology.
Valvular Interventions
By Ted E. Feldman, MD, FESC, FACC, FSCAI
Abbott’s MitraClip G4 Granted CE Mark in Europe to Treat Mitral Regurgitation
September 21, 2020—Abbott announced it has received European CE Mark approval for the fourth-generation MitraClip transcatheter mitral valve repair system, known as MitraClip G4.
TAVR: Insights and Perspectives
By Ted E. Feldman, MD, MSCAI, FACC, FESC, and Bernard Prendergast, BMedSci, BM BS, MRCP, DM, FRCP, FESC
Abbott’s TriClip and MitraClip Evaluated in Late-Breaking Clinical Science Presentations
October 24, 2023—Abbott announced data from late-breaking presentations of studies evaluating its minimally invasive heart devices in treating mitral and tricuspid valve disease.
